About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,360 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,360 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1881-1900 of 11,360 trials

AvailableAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGThis is an open-label, expanded access trial designed to provide access to cretostimogene in patients with NMIBC (specifically CIS with or without HG Ta/T1) unresponsive to BCG.NCT06443944·Gilbert, Arizona and 26 others TerminatedIrrisept Versus Standard of Care in the Prevention of Surgical Site InfectionsThe purpose of this study was to compare the rate of surgical site infections in patients randomized to Irrisept versus SoC, who had an open abdominal laparotomy for abdominal…NCT02255487·Tucson, Arizona and 16 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

CompletedMOMCare: Culturally Relevant Treatment Services for Perinatal DepressionThe study will evaluate the effectiveness of a culturally relevant, multi-component intervention for antenatal depression.NCT01045655·Seattle, Washington

TerminatedStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)This study is an open-label Phase 1/2 evaluation of CB-839 in combination with nivolumab in participants with clear cell renal cell carcinoma, melanoma, and non-small cell lung…NCT02771626·Scottsdale, Arizona and 16 others

CompletedObservational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic StrokeThe purpose of this study is to evaluate the utility of the S-STREAM as an instrument to assess motor function in subjects who have experienced a nonhemorrhagic ischemic stroke.NCT01496885·Newport Beach, California and 26 others

CompletedVorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AMLThe purpose of this study is to test the safety of vorinostat (Zolinza) and azacitidine (Vidaza) when combined with gemtuzumab ozogamicin (GO) at different dose levels.NCT00895934·Stanford, California and 3 others

CompletedCombination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaRATIONALE: Drugs used in chemotherapy such as fludarabine use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006233·Seattle, Washington

CompletedReducing Sugared Fruit Drinks in Alaska Native ChildrenThis study in Alaska will test whether providing sugar-free alternatives to sugared fruit drinks and introducing education and social support will help families and children to…NCT05219448·Seattle, Washington

CompletedAn Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple MyelomaThis study is a multi-cohort, open-label, multicenter Phase 2 study to evaluate the efficacy and safety of bb2121 in participants with relapsed and refractory multiple myeloma…NCT03601078·Scottsdale, Arizona and 24 others

CompletedRelapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in…NCT04410978·Birmingham, Alabama and 178 others

Active not recruitingStudy to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyThe study will evaluate the safety and efficacy of gene therapy in boys with DMD.NCT04281485·Little Rock, Arkansas and 52 others

CompletedStudy of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant TherapyTo explore the anti-impulsive and anti-aggressive properties of brexpiprazole in a naturalistic setting of depressed patients with irritability.NCT01942785·Tucson, Arizona and 14 others

CompletedEnteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) IntoleranceTreatment with the immunosuppressive drug mycophenolate mofetil (MMF) may result in gastrointestinal (GI) complications in some patients.NCT00400400·Phoenix, Arizona and 52 others

Active not recruitingChemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic LeukemiaThis phase II clinical trial tests a chemotherapy regimen (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin with or without rituximab…NCT05453500·Seattle, Washington

CompletedA Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid MalignanciesThis study consists of two phases: the first portion of the study is a Phase 1 dose escalation study to determine the maximum tolerated dose and the dose limiting toxicities of…NCT00719836·Chicago, Illinois and 2 others

CompletedComparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerThis Phase 3 study has been designed to confirm that adding custirsen to standard first-line docetaxel/prednisone treatment can slow tumor progression and enhance survival…NCT01188187·Birmingham, Alabama and 139 others

TerminatedStrategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology driven by ongoing…NCT05605093·Birmingham, Alabama and 186 others

CompletedA Study of Diazoxide Choline in Patients With Prader-Willi SyndromeThe purpose of this is study is to evaluate the effects of DCCR (diazoxide choline controlled release tablets) in children and adults with Prader-Willi syndrome.NCT03440814·Orange, California and 28 others

Active not recruitingA Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionThis is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic…NCT06903338·Chandler, Arizona and 38 others

No longer availableExpanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast CancerThis is an expanded access protocol to allow continued maintenance therapy with ABT-888 (veliparib) for three patients with metastatic triple negative breast cancer who are…NCT02985658·Seattle, Washington

PreviousPage 95 of 568Next

in Seattle

Heart Diseasein Seattle